Connect your AI

Arcosa ACA Business Combination Consideration Transferred1

Business Combination Consideration Transferred1 at other companies

AllegionALLE

$69.9M+508%

Willis Towers WatsonWTW

$1.05B—

Arthur J. GallagherAJG

$403M—

Henry ScheinHSIC

$0-100%

Natera, Inc.NTRA

-$213K—

PTC TherapeuticsPTCT

$800K+700%

Segments

By segment

Construction Products$60M-95.0%

Other financials

Income statement

Revenue$571.7M+4.4%

Gross profit$120.9M+12.0%

Operating income$47.1M+14.9%

Net income$37.8M+60.2%

EPS (diluted)$0.77+60.4%

Balance sheet

Cash & equivalents$153.2M-8.8%

Total debt$1.6B-9.9%

Total equity$2.7B+8.1%

Total assets$5.0B+1.4%

Cash flow

Operating cash flow$71.9M+10,371%

CapEx$43.5M+31.8%

Free cash flow$28.4M+184%

Valuation

Market cap$6.67B+38.4%

Enterprise value$8.1B+24.0%

P/E30×-26.2×

P/S2.4×+0.4×

Profitability

Gross margin22.8%+2.5pp

Operating margin11.8%+4.5pp

Net margin7.9%+4.5pp

FCF margin8.4%-2.0pp

Returns & leverage

Return on equity8.7%+5.2pp

Debt / equity0.6×-0.1×

Current ratio2.3×+0.3×